NEJM:弥漫性皮下气肿-病例报道

2019-04-11 xing.T 网络

肺气肿可以作为纵隔气肿的并发症发生,并且通常在没有干预的情况下消退。在住院第7天,患者的哮喘恶化得到了解决,他出院后间歇性接受沙丁胺醇治疗,并且泼尼松逐渐减量。眼睑肿胀在2周内缓慢消退。

患者为一名患有哮喘病史的14岁男孩,因喘息和咳嗽1天而到急诊就诊。当他呼吸周围空气时,他的初始氧饱和度为83%。

体检时可见明显的弥漫性喘息,并进行辅助通气。他接受了沙丁胺醇、异丙托溴铵、静脉注射镁和静脉注射糖皮质激素治疗,并因严重的哮喘急性发作而住院。两天后,他的呼吸窘迫和喘息恶化,并转移到儿科重症监护病房接受沙丁胺醇治疗。颈部肿胀和褶皱也随之发生。



胸部X线片检查发现包含弥漫性皮下气肿的纵隔气肿(如图A箭头所示)。四天后,随着他的呼吸状态改善,在脸颊和右眼睑均出现突然肿胀和可触及的捻发音(如图B所示)。他没有相关的眼痛或复视,眼外运动完好无损。

肺气肿可以作为纵隔气肿的并发症发生,并且通常在没有干预的情况下消退。在住院第7天,患者的哮喘恶化得到了解决,他出院后间歇性接受沙丁胺醇治疗,并且泼尼松逐渐减量。眼睑肿胀在2周内缓慢消退。

原始出处:

Tiffany M. St. Clair,et al.Diffuse Subcutaneous Emphysema.N Engl J Med 2019;https://www.nejm.org/doi/full/10.1056/NEJMicm1811009

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2032671, encodeId=5f1b20326e1d9, content=<a href='/topic/show?id=eefce192928' target=_blank style='color:#2F92EE;'>#皮下气肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71929, encryptionId=eefce192928, topicName=皮下气肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Fri Nov 15 13:01:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438607, encodeId=eeb4143860ec2, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50041, encryptionId=9851500416c, topicName=弥漫性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Apr 12 23:01:00 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034781, encodeId=90f91034e8183, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 11 11:01:00 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2032671, encodeId=5f1b20326e1d9, content=<a href='/topic/show?id=eefce192928' target=_blank style='color:#2F92EE;'>#皮下气肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71929, encryptionId=eefce192928, topicName=皮下气肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Fri Nov 15 13:01:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438607, encodeId=eeb4143860ec2, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50041, encryptionId=9851500416c, topicName=弥漫性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Apr 12 23:01:00 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034781, encodeId=90f91034e8183, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 11 11:01:00 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2032671, encodeId=5f1b20326e1d9, content=<a href='/topic/show?id=eefce192928' target=_blank style='color:#2F92EE;'>#皮下气肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71929, encryptionId=eefce192928, topicName=皮下气肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eba113, createdName=xiaoyeshuang, createdTime=Fri Nov 15 13:01:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438607, encodeId=eeb4143860ec2, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50041, encryptionId=9851500416c, topicName=弥漫性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Apr 12 23:01:00 CST 2019, time=2019-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034781, encodeId=90f91034e8183, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 11 11:01:00 CST 2019, time=2019-04-11, status=1, ipAttribution=)]
    2019-04-11 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0